← Browse by Condition
Medical Condition

tuberculosis tb

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 4

ClinicalMetric tracks all active clinical trials for tuberculosis tb sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — tuberculosis tb Clinical Trials

How many clinical trials are currently recruiting for tuberculosis tb?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for tuberculosis tb, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for tuberculosis tb?
tuberculosis tb research spans Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a tuberculosis tb clinical trial?
Eligibility criteria for tuberculosis tb trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 4
1
Top Sponsors
Mahidol University 1 trial
University of Toronto 1 trial
IRCCS Azienda Ospedaliero-Universitaria di Bologna 1 trial
University of Malaya 1 trial

Recruiting Clinical Trials

NCT06484530 Phase 4
Recruiting

Gene-guided N-acetyl Cysteine for Prophylaxis of Anti-tuberculous Drug- Induced Hepatitis

Enrollment
116 pts
Location
Thailand
Sponsor
Mahidol University
View Trial →
NCT06702774
Recruiting

Research on Key Interventional Technologies for Controlling the Epidemic in High-prevalence Areas of Tuberculosis in Guangxi, China

Enrollment
72,000 pts
Location
China
Sponsor
University of Toronto
View Trial →
NCT06764576
Recruiting

Patients With Tuberculosis, Mycobacteriosis or Latent Tuberculosis

Enrollment
13,000 pts
Location
Italy
Sponsor
IRCCS Azienda Ospedaliero-Univ...
View Trial →
NCT07069387
Recruiting

Pharmacist-led Digital Interventions to Improve Tuberculosis Treatment Adherence

Enrollment
160 pts
Location
Malaysia
Sponsor
University of Malaya
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology